Saltar al contenido
Merck
Todas las fotos(1)

Documentos

F0040010

Carbendazim

European Pharmacopoeia (EP) Reference Standard

Sinónimos:

Carbendazim, BCM, Methyl 2-benzimidazolecarbamate, Methyl benzimidazol-2-ylcarbamate

Iniciar sesiónpara Ver la Fijación de precios por contrato y de la organización
Todas las fotos(1)

About This Item

Fórmula empírica (notación de Hill):
C9H9N3O2
Número de CAS:
10605-21-7
Peso molecular:
191.19
Beilstein/REAXYS Number:
649044
MDL number:
MFCD00055390
UNSPSC Code:
41116107
PubChem Substance ID:
329799622
NACRES:
NA.24

grade

pharmaceutical primary standard

API family

fenbendazole

manufacturer/tradename

EDQM

mp

>300 °C (lit.)

application(s)

pharmaceutical (small molecule)

format

neat

storage temp.

2-8°C

SMILES string

COC(=O)Nc1nc2ccccc2[nH]1

InChI

1S/C9H9N3O2/c1-14-9(13)12-8-10-6-4-2-3-5-7(6)11-8/h2-5H,1H3,(H2,10,11,12,13)

InChI key

TWFZGCMQGLPBSX-UHFFFAOYSA-N

¿Está buscando productos similares? Visita Guía de comparación de productos

General description

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Application

Fenbendazole impurity A EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.

Packaging

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

Other Notes

Sales restrictions may apply.

related product

Referencia del producto
Descripción
Precios

1269403

Fenbendazole, United States Pharmacopeia (USP) Reference Standard

F0040000

Fenbendazole, European Pharmacopoeia (EP) Reference Standard

F0040020

Fenbendazole impurity B, European Pharmacopoeia (EP) Reference Standard

1269414

Carbendazim, United States Pharmacopeia (USP) Reference Standard

1269425

Fenbendazole Related Compound B, United States Pharmacopeia (USP) Reference Standard

PHR1832

Fenbendazole, Pharmaceutical Secondary Standard; Certified Reference Material

BP692

Fenbendazole, British Pharmacopoeia (BP) Reference Standard

PHR2863

Fenbendazole Related Compound B, certified reference material, pharmaceutical secondary standard

signalword

Danger

Hazard Classifications

Aquatic Acute 1 - Aquatic Chronic 1 - Muta. 1B - Repr. 1B - Skin Sens. 1

Storage Class

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

wgk_germany

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

Choose from one of the most recent versions:

Certificados de análisis (COA)

Lot/Batch Number

Sorry, we don't have COAs for this product available online at this time.

If you need assistance, please contact Atención al cliente

¿Ya tiene este producto?

Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.

Visite la Librería de documentos

Christoph Thalhammer et al.
Nephrology (Carlton, Vic.), 20(2), 91-95 (2014-10-28)
Haemodynamic stability of patients during haemodialysis (HD) sessions is of pivotal importance and accurate determination of dry weight remains a challenge. Little information is available about central venous and aortic pressure during dialysis. In this pilot study we used a
Przemyslaw Szafranski et al.
European journal of human genetics : EJHG, 23(2), 173-179 (2014-05-16)
Genomic copy-number variations (CNVs) constitute an important cause of epilepsies and other human neurological disorders. Recent advancement of technologies integrating genome-wide CNV mapping and sequencing is rapidly expanding the molecular field of pediatric neurodevelopmental disorders. In a previous study, a
Bin He et al.
Proceedings of the National Academy of Sciences of the United States of America, 111(51), 18261-18266 (2014-12-10)
The androgen receptor (AR) is a key driver of prostate cancer (PC), even in the state of castration-resistant PC (CRPC) and frequently even after treatment with second-line hormonal therapies such as abiraterone and enzalutamide. The persistence of AR activity via
Ismail Kocyigit et al.
Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis, 34(7), 781-790 (2014-01-05)
In this study our aim was to evaluate the relationship between degree of fluid status and arterial stiffness measured by pulse wave velocity (PWV) in peritoneal dialysis (PD) patients. Fluid status was determined by different methods including fluid overload measured
Petra Hegerová et al.
Nutrition (Burbank, Los Angeles County, Calif.), 31(1), 166-170 (2014-12-04)
An acute disease is regularly associated with inflammation, decreased food intake, and low physical activity; the consequence is loss of muscle mass. However, the restoration of muscle tissue is problematic, especially in older patients. Loss of muscle mass leads to
Ver todos los artículos relacionados

Nuestro equipo de científicos tiene experiencia en todas las áreas de investigación: Ciencias de la vida, Ciencia de los materiales, Síntesis química, Cromatografía, Analítica y muchas otras.

Póngase en contacto con el Servicio técnico